Graves’ disease following interferon therapy for chronic hepatitis C infection

Omayma El Shafie*, Samir Hussein, Waheed El Awady, Nicholas Woodhouse

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


We describe the first case of Graves’ disease occurring at Sultan Qaboos University Hospital, Oman, in a patient who was under treatment with interferon alfa for HCV infection. INF-α is now being widely used to treat patients with a variety of disorders including infection with hepatitis C virus. Clinical thyroid disease, hypo and hyperthyroidism can occur in up to 15% of patients. We emphasize the need for thyroid function screening before and during therapy to identify patients early in the course of their disease..

Original languageEnglish
Pages (from-to)75-77
Number of pages3
JournalSultan Qaboos University Medical Journal
Issue number1
Publication statusPublished - Mar 2008


  • Antibodies, Thyroid
  • Case report, Oman
  • Interferon
  • Thyroid function test
  • Thyrotoxicosis

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Graves’ disease following interferon therapy for chronic hepatitis C infection'. Together they form a unique fingerprint.

Cite this